Skip to main content
NVDA-1.22%AAPL+0.52%GOOGL-2.28%MSFT-0.62%AMZN-0.71%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.68%TSLA-1.98%SKHY+7.05%MU-2.78%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.59%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.40%0005.HK-0.78%HSBA.L-1.76%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.45%AUDJPY-1.72%CHFJPY-1.69%NZDCAD-1.37%NZDUSD-1.36%GBPJPY-1.29%EURJPY-1.28%EURNZD+1.21%GBPNZD+1.17%USDJPY-1.12%CADJPY-1.10%USDZAR+0.93%USDSEK+0.90%USDNOK+0.88%NZDCHF-0.79%AUDNZD+0.76%USDTHB+0.66%AUDCAD-0.65%AUDUSD-0.61%USDPLN+0.60%EURZAR+0.59%USDCHF+0.59%CADCHF+0.58%EURSEK+0.55%EURNOK+0.54%USDMXN+0.53%GBPZAR+0.52%AUDSGD-0.52%AUDDKK-0.47%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.39%CHFSEK+0.36%EURHKD-0.36%CHFNOK+0.35%USDDKK+0.34%NZDSGD-0.34%SGDJPY+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%NOKJPY-0.26%EURPLN+0.26%CHFSGD-0.24%EURCNH-0.23%GBPCAD-0.21%EURCAD-0.19%EURUSD-0.17%GBPUSD-0.17%USDILS+0.16%NZDMXN-0.12%GBPSGD-0.12%USDTRY+0.11%USDCNH+0.09%AUDNOK+0.07%EURSGD-0.05%USDCOP-0.04%AUDCHF-0.03%EURGBP+0.02%PLNJPY+0.02%EURCZK-0.01%USDCAD-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.99%XAGUSD-4.94%GAGUSD-4.91%HG1-4.38%USOIL+3.84%UKOIL+3.77%COFFEE-1.97%GAUUSD-1.74%XAUUSD-1.72%SUGAR+0.87%S1+0.86%C1+0.66%BTCUSD-1.53%ETHUSD-1.38%USDTUSD-0.04%XRPUSD-1.99%SOLUSD-1.56%TRXUSDT+0.15%ZECUSDT-2.42%DOGEUSD-1.93%XMRUSDT-1.84%LINKUSD-0.96%XLMUSD-1.67%BCHUSDT-3.83%LTCUSD-2.04%UNIUSD-2.80%TONUSD+24.88%HBARUSDT-2.07%SUIUSD-2.03%TAOUSDT-2.79%AAVEUSD-2.74%DOTUSDT-2.18%ICPUSDT-1.62%ONDOUSDT-2.73%WLDUSDT-1.47%ATOMUSDT-2.87%ARBUSDT-0.68%JUPUSDT-3.39%INJUSDT-2.47%STXUSDT-3.80%FETUSDT-3.18%TIAUSDT-1.13%PYTHUSDT-1.34%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-3.42%GRTUSDT-3.93%OPUSDT-1.99%POLUSDT-6.32%IOTAUSDT-3.86%AXSUSDT-2.47%FARTCOINUSDT-4.25%EOSUSDT-0.19%DYDXUSDT-0.49%ORDIUSDT-0.44%GALAUSDT-3.93%NOTUSDT-0.68%RONINUSDT-2.64%NVDA-1.22%AAPL+0.52%GOOGL-2.28%MSFT-0.62%AMZN-0.71%TSM-0.83%SPCX-3.86%AVGO-1.13%META-0.68%TSLA-1.98%SKHY+7.05%MU-2.78%BRK-B+0.18%LLY+0.02%JPM+0.34%AMD+3.04%WMT-0.21%V-0.34%XOM+2.24%ASMLa-2.59%JNJ-0.76%INTC+1.69%MA-0.59%0700.HK-1.94%ORCL-0.50%1398.HK+0.79%BAC+0.45%ABBV+0.88%CSCO+0.24%CVX+1.91%COST-0.83%LRCX-1.43%KO-0.92%CAT-0.84%AMAT-0.83%AP2d-2.40%0005.HK-0.78%HSBA.L-1.76%UNH-1.94%DELL+0.29%MS-0.42%PG-2.02%GE-2.83%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.96%HD-1.04%GS-0.75%0939.HK+1.66%NZDJPY-2.45%AUDJPY-1.72%CHFJPY-1.69%NZDCAD-1.37%NZDUSD-1.36%GBPJPY-1.29%EURJPY-1.28%EURNZD+1.21%GBPNZD+1.17%USDJPY-1.12%CADJPY-1.10%USDZAR+0.93%USDSEK+0.90%USDNOK+0.88%NZDCHF-0.79%AUDNZD+0.76%USDTHB+0.66%AUDCAD-0.65%AUDUSD-0.61%USDPLN+0.60%EURZAR+0.59%USDCHF+0.59%CADCHF+0.58%EURSEK+0.55%EURNOK+0.54%USDMXN+0.53%GBPZAR+0.52%AUDSGD-0.52%AUDDKK-0.47%EURAUD+0.45%GBPAUD+0.42%GBPTRY+0.41%EURCHF+0.40%GBPCHF+0.39%CHFSEK+0.36%EURHKD-0.36%CHFNOK+0.35%USDDKK+0.34%NZDSGD-0.34%SGDJPY+0.33%GBPHKD+0.32%USDSGD+0.29%GBPMXN-0.28%NOKJPY-0.26%EURPLN+0.26%CHFSGD-0.24%EURCNH-0.23%GBPCAD-0.21%EURCAD-0.19%EURUSD-0.17%GBPUSD-0.17%USDILS+0.16%NZDMXN-0.12%GBPSGD-0.12%USDTRY+0.11%USDCNH+0.09%AUDNOK+0.07%EURSGD-0.05%USDCOP-0.04%AUDCHF-0.03%EURGBP+0.02%PLNJPY+0.02%EURCZK-0.01%USDCAD-0.01%USDHKD+0.01%EURDKK0.00%XPTUSD-4.99%XAGUSD-4.94%GAGUSD-4.91%HG1-4.38%USOIL+3.84%UKOIL+3.77%COFFEE-1.97%GAUUSD-1.74%XAUUSD-1.72%SUGAR+0.87%S1+0.86%C1+0.66%BTCUSD-1.53%ETHUSD-1.38%USDTUSD-0.04%XRPUSD-1.99%SOLUSD-1.56%TRXUSDT+0.15%ZECUSDT-2.42%DOGEUSD-1.93%XMRUSDT-1.84%LINKUSD-0.96%XLMUSD-1.67%BCHUSDT-3.83%LTCUSD-2.04%UNIUSD-2.80%TONUSD+24.88%HBARUSDT-2.07%SUIUSD-2.03%TAOUSDT-2.79%AAVEUSD-2.74%DOTUSDT-2.18%ICPUSDT-1.62%ONDOUSDT-2.73%WLDUSDT-1.47%ATOMUSDT-2.87%ARBUSDT-0.68%JUPUSDT-3.39%INJUSDT-2.47%STXUSDT-3.80%FETUSDT-3.18%TIAUSDT-1.13%PYTHUSDT-1.34%SEIUSDT-3.91%IMXUSDT-2.27%WIFUSDT-3.42%GRTUSDT-3.93%OPUSDT-1.99%POLUSDT-6.32%IOTAUSDT-3.86%AXSUSDT-2.47%FARTCOINUSDT-4.25%EOSUSDT-0.19%DYDXUSDT-0.49%ORDIUSDT-0.44%GALAUSDT-3.93%NOTUSDT-0.68%RONINUSDT-2.64%
XE

Xencor, Inc. (XNCR)

NASDAQ • Healthcare

$24.94
-$0.38 (-1.5%)
Market closed

Last close at September 9, 2026 at 20:00 UTC

Open$25.12
Day Range$24.85 - $26.18
Avg. Volume (3M)1.4M
Market Cap$1.8B
52 Week Range
$8.26$30.61
Next EarningsIn 55 daysNov 4, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$51.2M100%
Gross Profitminus cost of goods$51.2M100%

In plain terms: out of every $100 in revenue, Xencor, Inc. currently loses $42.

Fundamentals & Financials

Revenue (TTM)
$104.9M
Net Income (TTM)
-$163.3M
EPS (TTM)
-$2.17
ROA (TTM)
-22.53%
Current Ratio
6.39

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+85.9%Q1 2026-$0.09
-163.1%Q2 2026-$1.71
+63.8%Q3 2026-$0.29
Next

Nov 4

in 55 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Xencor, Inc.

Xencor, Inc. is a NASDAQ-listed biotechnology company that discovers and engineers monoclonal antibody and cytokine therapeutics, mainly for cancer and autoimmune disorders. In FY2025, it generated $125.6 million in revenue. Its marketed and partnered programs include Sotrovimab, Ultomiris, and Monjuvi.

Name
Xencor, Inc.
CEO
Bassil I. Dahiyat
Website
www.xencor.com
Industry
Healthcare
Year Founded
1997
Employees
260

Today's Snapshot

AI-generated

XNCR closed 1.5% lower at 24.94.

Trading Volume

Below 10d avg (1.5M)

1.1M

vs S&P 500 Today

Underperforming Market

-1.06%

Updated: September 10, 2026 at 12:13 UTC

Technical Indicators

4 Buy2 Neutral2 Sell
XNCR shows a buy tilt driven more by longer-term moving averages and strong trend strength than by short-term momentum. ADX registers as firmly positive, indicating a robust directional trend, while short EMAs and SMAs sit above the current price and register as short-term sellers, suggesting recent weakness. Momentum measures are mixed—RSI sits near neutral and MACD is muted—while volatility is moderate and ATR points to meaningful intraday ranges. On balance, volume-based OBV is negative but classic pivot sits slightly above the market, implying resistance nearby. Technical takeaway: trend strength supports a buy stance despite short-term weakness.
All signals
  • EMA (5 indicators)$16.58 - $26.33
    Buy
  • RSI (14)50.69
    Neutral
  • Stochastic %K (14, 3, 3)19.15
    Buy
  • MACD Level (12, 26)1.37
    Neutral

Peers & Related Assets

TNGXTango Therapeutics, Inc.
$24+5.7%
NRIXNurix Therapeutics, Inc.
$26.26+0.5%
URGNUroGen Pharma Ltd.
$45+2.7%
KODKodiak Sciences Inc.
$33.78-3.7%
ANABAnaptysBio, Inc.
$55.7-1.6%
PHATPhathom Pharmaceuticals, Inc.
$8.67-8.1%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.